Elka Palant

Title: Elka Palant: Innovator in Conotoxin Peptides

Introduction

Elka Palant is a distinguished inventor based in Kenmore, Australia. She has made significant contributions to the field of biochemistry, particularly in the development of conotoxin peptides. With a total of two patents to her name, her work has the potential to impact various medical conditions.

Latest Patents

Elka's latest patents include innovative peptides that have therapeutic applications. The first patent involves an isolated, synthetic, or recombinant χ-conotoxin peptide with a specific amino acid sequence. This peptide is designed for the prophylaxis or treatment of conditions such as pain, inflammation, incontinence, cardiovascular issues, and mood disorders. The second patent focuses on Type II chi-conotoxin peptides, which act as noradrenaline transporter inhibitors. This peptide also has a defined amino acid sequence and is aimed at inhibiting neuronal amine transporters.

Career Highlights

Elka Palant is currently associated with Xenome Limited, a company that specializes in the development of peptide-based therapeutics. Her work at Xenome has positioned her as a key player in the field of pharmaceutical innovations.

Collaborations

Elka has collaborated with notable scientists in her field, including Richard James Lewis and Paul Francis Alewood. These collaborations have further enhanced her research and development efforts.

Conclusion

Elka Palant's contributions to the field of conotoxin peptides demonstrate her innovative spirit and commitment to advancing medical science. Her patents hold promise for treating various health conditions, showcasing the importance of her work in the pharmaceutical industry.